THE LEFT INTERNAL mammary artery (IMA) and the aortocoronary saphenous vein graft (SVG) have both been widely used as bypass grafts in treating critical stenoses of the left anterior descending (LAD) coronary artery. However, many surgeons prefer the autogenous vein graft because of theoretical and practical disadvantages of the IMA, which include 1) lower potential maximal flow through the smaller conduit that might be inadequate to prevent ischemia or infarction in the hypertrophied myocardium or during times of stress;' 2) the more complex and timeconsuming procedure required to mobilize the IMA, making it less suitable in hemodynamically unstable patients and potentially depressing respiratory function2 and increasing the incidence of postoperative bleeding and wound complications; 3) the smaller size and fragility of the IMA increases the technical difficulty in constructing the anastomosis.3''
Proponents of IMA grafts cite in their favor 1) high late patency rates;3 [5] [6] [7] [8] 2) morphologic changes, including intimal hyperplasia and atherosclerotic occlusion occurring in some saphenous vein-grafts placed in arterial positions;9 '-3) favorable comparisons between groups of patients with patent IMA-to-LAD grafts and SVG-to-LAD grafts undergoing exercise testing;6' 12 and 4) elimination of the aortovenous anastomosis. 8 To compare the late results of bypass grafting using the IMA and saphenous vein as conduits, two series of 100 consecutive patients undergoing revascularization as treatment of isolated LAD stenosis were surveyed.
One group received SVG-to-LAD grafts; the other, IMA-to-LAD grafts. Follow-up focused on complications, symptom response, angiographic data on the graft and the host vessel and survival. We also present late results in 200 patients who underwent surgical treatment of isolated LAD stenosis.
Methods

Patient Population
Direct IMA-to-LAD grafts have been performed at the Cleveland Clinic since 1971. To eliminate the possible influence of technical inexperience, the first 50 patients who received IMA-to-LAD grafts were excluded. Thus Abbreviations: IMA = internal mammary artery; SVG = saphenous vein graft; NYHA = New York Heart Association. However, when the entire group of 200 patients was divided into two subgroups on the basis of presence or absence of preoperative angiographic evidence of noncritical disease of coronary arteries other than the LAD, the combined incidence of these major events was significantly higher (p = 0.023) in the group with disease ( fig. 1) .
The location of preoperative LAD stenosis relative to the first septal perforator had no relationship to the incidence of postoperative complication or death.
Arteriography
Postoperative cine coronary arteriography confirmed that 42 of 46 patients in the IMA group and 44 of 56 in the SVG group had patent grafts (p < 0.10). As expected, the patency rate of grafts in patients catheterized routinely was higher than in those catheterized for symptoms ( reoperation) and five of the six with progression in two vessels underwent reoperation.
Clinical Follow-up Eighty-two patients in the IMA group and 81 in the SVG group were angina-free at late follow-up (table  5 ). In the SVG group, four asymptomatic patients either had an interim infarction or had undergone reoperation. Thus, 77 patients in that group were asymptomatic at late follow-up and had experienced a benign interim course. Fifteen patients in each group were classified as having NYHA functional class II angina, one patient in each group was classified as class III, and one SVG patient was classified as class IV. Of the 196 survivors, two IMA patients had deteriorated one functional class compared with their preoperative status and 10 patients who were symptomatic preoperatively were in the same functional class at late follow-up. All other patients who were symptomatic preoperatively were improved at least one functional class at late follow-up. When subgroups of patients characterized by the presence of noncritical atherosclerotic lesions in vessels other than the LAD or the presence of distal LAD disease were compared with the total group, there was no difference in late functional class.
The functional class in the subgroup of patients with patent grafts at recatheterization was also reviewed: five of 41 in the IMA group were mildly symptomatic (class II) and three of 43 in the SVG group had mild angina.
Discussion
Our results indicate a slightly higher late patency rate for IMA grafts to the LAD coronary artery than for SVGs to the same vessel. Similar observations have been reported by others. 5 6, 8 Because the IMAto-coronary-artery anastomosis is technically more Abbreviations: IMA = internal mammary artery; SVG = saphenous vein graft; NYHA = New York Heart Association.
difficult and the vessels in this study grafted with the IMA tended to have poorer runoff compared with vessels grafted with veins, the favorable late patency rate of IMA grafts seems to stem from intrinsic properties of the conduit itself. The even caliber of the IMA may provide nonturbulent flow at a higher velocity for a given outflow bed than does the larger, more irregular saphenous vein.'5 Graft flow is autoregulated by the peripheral coronary resistance and the IMA, unlike the SVG, tends to remain open in low-flow states. Also, some saphenous-vein-to-coronary grafts have been shown to develop atherosclerosis or intimal hyperplasia,91l which has not been reported in IMA grafts.
Host vessels with subtotal obstruction preoperatively grafted with an IMA had a lower rate of total occlusion at postoperative angiography than vessels grafted with a vein. In theory, this could be due to a lower rate of flow through the IMA, with some flow being maintained across the proximal obstruction in the host vessel. Though the smaller size of the IMA may be an advantage in maintaining both graft and host vessel patency, the lower potential maximum flow through this vessel could be a disadvantage. Flemma et al.' correctly pointed out that patency is not the only consideration in graft evaluation. However, the low rate of postoperative angina in the IMA group seems to indicate that although the potential maximum flow through the IMA is less than that through a vein, it nonetheless relieves angina in patients with isolated LAD stenosis. This has been supported by exercise data concerning patients with IMA grafts. 6' 12 Further, the IMA graft has been noted to increase in size at late postoperative recatheterization, indicating that the IMA graft may have some capacity to increase flow in relation to demand.3 Finally, the rate of nonfatal postoperative infarction was not significantly different between the IMA and SVG groups.
When the difference in follow-up between the SVG and IMA groups was eliminated by actuarial methods, there was no statistically significant difference in the rate of infarction, death and reoperation, or in late NYHA functional class.
Preoperative angiographic evidence of noncritical disease in the right and circumflex arteries correlated positively with the combined incidence of death, infarction and reoperation. Disease progression in nongrafted vessels appears to be the major factor limiting palliation achieved by LAD revascularization. We do not advocate postponement of surgery until noncritical lesions in other vessels progress further. Information about the natural progression of obstructive coronary arterial disease is derived from sequential arteriograms.16 It is impossible to predict which minor arterial lesion would progress. Severe obstructions often progressed within the first year whereas less severe lesions tended to progress within 3-6 years. It is our opinion that awaiting further progression of noncritical lesions in patients with severe LAD narrowing is risky due to the unpredictable nature of the process. Further data concerning long-term graft and host vessel patency after grafting of noncritically obstructed vessels are needed before these decisions can be made accurately. Progression of disease in the distal portion of the LAD was not noted in recatheterized patients.
Preoperatively, approximately half of these patients were considered to have NYHA13 functional class II angina pectoris, i.e., angina with ordinary physical activity. Generally, this older classification signifies more severe angina than more recent American Heart Association and Canadian Cardiovascular Society classification at the same level.
Long-term relief of angina was excellent in both groups. Eighty-two patients in the IMA group and 77 patients in the SVG group were asymptomatic, with no interim infarction or reoperation. There was not, however, an exact correlation between graft patency and relief of symptoms; seven of the 16 patients with grafts known to be occluded were asymptomatic at late follow-up without having undergone interim reoperation.
The goal of surgical treatment in patients with coronary artery disease is to relieve ischemia by establishing functioning grafts distal to critical stenoses. The risk of the operation required to reach that goal and the incidence of graft failure must be weighed against the risk of mortality and the persistence of symptoms inherent in the natural history of the disease. Revascularization clearly provides excellent relief of symptoms, and improvement in ventricular function has been shown after single-vessel grafting.17 However, the relative efficacy of surgical and medical treatment of isolated LAD stenosis remains in doubt because a number of studies have shown relatively favorable survival of medically treated patients with single-vessel disease.18' 19 Burggraf and Parker20 reported that 51 patients with isolated LAD disease treated medically had an 87% survival over 5 years. A group of 28 angiographic surgical candidates with similar lesions from the Cleveland Clinic nonsurgical series had an 89% 5-year and a 76% 10-year survival. 21 However, though isolated LAD stenosis is relatively less life-threatening statistically than two-vessel or three-vessel disease, the risk of death over 5-10 years documented by these studies is not negligible. Further, angiographic study of a group of patients resuscitated from "sudden death" arrhythmias has shown 14 of 79 with isolated LAD disease. 22 Retrospective nonsurgical series do not provide a control group for our retrospective surgical group. They do show, however, that isolated LAD stenosis carries a risk of death, and that to provide effective palliation, surgery for this condition must be performed with low morbidity and almost no mortality. We believe this goal can be achieved. Ninety-eight percent of these 200 patients are alive after a mean follow-up of 67 months. No perioperative mortality occurred and only 1 % died of late cardiac causes in the first 5 postoperative years. This group of patients appears to have been afforded relief of the symptoms and complications of ischemic heart disease at a low risk.
